| Phillip D Compton Ii, MD | |
|
15286 Community Rd, Gulfport, MS 39503-3509 | |
| (228) 832-5151 | |
| (228) 832-6320 |
| Full Name | Phillip D Compton Ii |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 31 Years |
| Location | 15286 Community Rd, Gulfport, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578591186 | NPI | - | NPPES |
| 00121014 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 16438 (Mississippi) | Secondary |
| 207R00000X | Internal Medicine | 16438 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mississippi Homecare Of Picayune | Picayune, MS | Home health agency |
| Kare In Home Health Services | Gulfport, MS | Home health agency |
| Encompass Health Home Health Of Gulf Coast | Gulfport, MS | Home health agency |
| Saads Home Nursing Of Ms | Diberville, MS | Home health agency |
| Deaconess Homecare- Region 1 | Laurel, MS | Home health agency |
| Kare-in-home Hospice, Llc | Wiggins, MS | Hospice |
| Memorial Hospital At Gulfport | Gulfport, MS | Hospital |
| Merit Health Biloxi | Biloxi, MS | Hospital |
| Boyington Health And Rehabilitation | Gulfport, MS | Nursing home |
| Gulfport Care Center | Gulfport, MS | Nursing home |
| Memorial Woodland Village Nursing Center | Diamondhead, MS | Nursing home |
| Memorial Stone County Nursing & Rehabilitation Ctr | Wiggins, MS | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Exceed Physical Therapy Llc | 8123378338 | 82 |
| Memorial Hospital At Gulfport | 2466524012 | 376 |
News Archive
Reza Zarnegar and colleagues, at the University of Pittsburgh, Pittsburgh, have determined that genetic variation in a piece of DNA that regulates activity of the HGF gene might be a useful marker to identify individuals with an increased risk of developing breast cancer.
ConjuChem, LLC, a biotechnology company dedicated to the discovery of novel therapeutics, today announced it has initiated patient enrollment for its Phase 2 clinical trial of its proprietary GLP-1 receptor agonist drug, CJC-1134-PC, in patients with Type 2 diabetes mellitus who are receiving metformin monotherapy.
The U.S. Environmental Protection Agency (EPA) has awarded its ENERGY STAR certification to NewYork-Presbyterian Hospital/Weill Cornell Medical Center's flagship building at 525 East 68th Street - the only hospital facility certified in New York City in 2011.
Xcellerex, Inc. today announced that it has initiated a Phase I clinical trial of XRX-001, a novel, prophylactic vaccine against yellow fever, a tropical virus disease that is often fatal.
Dr. Jim Evans, an expert in gene patenting and genetics policy who has led a program to educate federal judges about the intricacies of genetics and genetic policy, says the ruling by United States District Court Judge Robert Sweet that invalidated seven patents related to the BRCA 1 and BRCA 2 genes "came as a surprise to everybody. It's really quite unusual for plaintiffs to get a summary judgment."
› Verified 1 days ago
| Entity Name | Primesource Nursing Services, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962573170 PECOS PAC ID: 7113966037 Enrollment ID: O20050429000745 |
News Archive
Reza Zarnegar and colleagues, at the University of Pittsburgh, Pittsburgh, have determined that genetic variation in a piece of DNA that regulates activity of the HGF gene might be a useful marker to identify individuals with an increased risk of developing breast cancer.
ConjuChem, LLC, a biotechnology company dedicated to the discovery of novel therapeutics, today announced it has initiated patient enrollment for its Phase 2 clinical trial of its proprietary GLP-1 receptor agonist drug, CJC-1134-PC, in patients with Type 2 diabetes mellitus who are receiving metformin monotherapy.
The U.S. Environmental Protection Agency (EPA) has awarded its ENERGY STAR certification to NewYork-Presbyterian Hospital/Weill Cornell Medical Center's flagship building at 525 East 68th Street - the only hospital facility certified in New York City in 2011.
Xcellerex, Inc. today announced that it has initiated a Phase I clinical trial of XRX-001, a novel, prophylactic vaccine against yellow fever, a tropical virus disease that is often fatal.
Dr. Jim Evans, an expert in gene patenting and genetics policy who has led a program to educate federal judges about the intricacies of genetics and genetic policy, says the ruling by United States District Court Judge Robert Sweet that invalidated seven patents related to the BRCA 1 and BRCA 2 genes "came as a surprise to everybody. It's really quite unusual for plaintiffs to get a summary judgment."
› Verified 1 days ago
| Entity Name | Memorial Hospital At Gulfport |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215546635 PECOS PAC ID: 2466524012 Enrollment ID: O20090515000396 |
News Archive
Reza Zarnegar and colleagues, at the University of Pittsburgh, Pittsburgh, have determined that genetic variation in a piece of DNA that regulates activity of the HGF gene might be a useful marker to identify individuals with an increased risk of developing breast cancer.
ConjuChem, LLC, a biotechnology company dedicated to the discovery of novel therapeutics, today announced it has initiated patient enrollment for its Phase 2 clinical trial of its proprietary GLP-1 receptor agonist drug, CJC-1134-PC, in patients with Type 2 diabetes mellitus who are receiving metformin monotherapy.
The U.S. Environmental Protection Agency (EPA) has awarded its ENERGY STAR certification to NewYork-Presbyterian Hospital/Weill Cornell Medical Center's flagship building at 525 East 68th Street - the only hospital facility certified in New York City in 2011.
Xcellerex, Inc. today announced that it has initiated a Phase I clinical trial of XRX-001, a novel, prophylactic vaccine against yellow fever, a tropical virus disease that is often fatal.
Dr. Jim Evans, an expert in gene patenting and genetics policy who has led a program to educate federal judges about the intricacies of genetics and genetic policy, says the ruling by United States District Court Judge Robert Sweet that invalidated seven patents related to the BRCA 1 and BRCA 2 genes "came as a surprise to everybody. It's really quite unusual for plaintiffs to get a summary judgment."
› Verified 1 days ago
| Entity Name | Keystone Hospitalist Services Of Ms Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932447968 PECOS PAC ID: 7517103864 Enrollment ID: O20130411000527 |
News Archive
Reza Zarnegar and colleagues, at the University of Pittsburgh, Pittsburgh, have determined that genetic variation in a piece of DNA that regulates activity of the HGF gene might be a useful marker to identify individuals with an increased risk of developing breast cancer.
ConjuChem, LLC, a biotechnology company dedicated to the discovery of novel therapeutics, today announced it has initiated patient enrollment for its Phase 2 clinical trial of its proprietary GLP-1 receptor agonist drug, CJC-1134-PC, in patients with Type 2 diabetes mellitus who are receiving metformin monotherapy.
The U.S. Environmental Protection Agency (EPA) has awarded its ENERGY STAR certification to NewYork-Presbyterian Hospital/Weill Cornell Medical Center's flagship building at 525 East 68th Street - the only hospital facility certified in New York City in 2011.
Xcellerex, Inc. today announced that it has initiated a Phase I clinical trial of XRX-001, a novel, prophylactic vaccine against yellow fever, a tropical virus disease that is often fatal.
Dr. Jim Evans, an expert in gene patenting and genetics policy who has led a program to educate federal judges about the intricacies of genetics and genetic policy, says the ruling by United States District Court Judge Robert Sweet that invalidated seven patents related to the BRCA 1 and BRCA 2 genes "came as a surprise to everybody. It's really quite unusual for plaintiffs to get a summary judgment."
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Phillip D Compton Ii, MD Po Box 1810, Gulfport, MS 39502 Ph: (228) 575-1194 | Phillip D Compton Ii, MD 15286 Community Rd, Gulfport, MS 39503-3509 Ph: (228) 832-5151 |
News Archive
Reza Zarnegar and colleagues, at the University of Pittsburgh, Pittsburgh, have determined that genetic variation in a piece of DNA that regulates activity of the HGF gene might be a useful marker to identify individuals with an increased risk of developing breast cancer.
ConjuChem, LLC, a biotechnology company dedicated to the discovery of novel therapeutics, today announced it has initiated patient enrollment for its Phase 2 clinical trial of its proprietary GLP-1 receptor agonist drug, CJC-1134-PC, in patients with Type 2 diabetes mellitus who are receiving metformin monotherapy.
The U.S. Environmental Protection Agency (EPA) has awarded its ENERGY STAR certification to NewYork-Presbyterian Hospital/Weill Cornell Medical Center's flagship building at 525 East 68th Street - the only hospital facility certified in New York City in 2011.
Xcellerex, Inc. today announced that it has initiated a Phase I clinical trial of XRX-001, a novel, prophylactic vaccine against yellow fever, a tropical virus disease that is often fatal.
Dr. Jim Evans, an expert in gene patenting and genetics policy who has led a program to educate federal judges about the intricacies of genetics and genetic policy, says the ruling by United States District Court Judge Robert Sweet that invalidated seven patents related to the BRCA 1 and BRCA 2 genes "came as a surprise to everybody. It's really quite unusual for plaintiffs to get a summary judgment."
› Verified 1 days ago
Dr. Nabil Azar, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1340 Broad Ave, Suite 310, Gulfport, MS 39501 Phone: 228-575-1400 Fax: 228-575-1414 | |
Dr. Fahad Javed, M.D., Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4215 15th St, Gulfport, MS 39501 Phone: 228-863-5211 Fax: 228-863-4101 | |
Indrajit J Patel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-867-5201 Fax: 228-867-3152 | |
James K. Campbell, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15190 Community Rd Ste 240, Gulfport, MS 39503 Phone: 228-575-7104 Fax: 228-539-6766 | |
Dr. Thomas Blanks, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1110 Broad Ave, Suite 700, Gulfport, MS 39501 Phone: 228-864-0314 Fax: 228-864-0425 | |
Dr. Stephanie Fussell, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1340 Broad Ave Ste 330, Gulfport, MS 39501 Phone: 228-575-1234 Fax: 228-867-4828 | |
Dr. Malcolm Scott Dean, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-867-5201 Fax: 228-867-3152 |